BlackRock Health Sciences Term Trust Files Proxy Statement
Ticker: BMEZ · Form: DEFA14A · Filed: May 28, 2024 · CIK: 1785971
| Field | Detail |
|---|---|
| Company | Blackrock Health Sciences Term Trust (BMEZ) |
| Form Type | DEFA14A |
| Filed Date | May 28, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, fund-management
TL;DR
BlackRock Health Sciences Term Trust filed its proxy statement on 5/28/24. Shareholders get info for voting.
AI Summary
BlackRock Health Sciences Term Trust (the "Trust") is filing a Definitive Proxy Statement (DEFA14A) on May 28, 2024. This filing concerns the Trust's operations and shareholder matters. The Trust is registered under the 1934 Act with SEC file number 811-23466.
Why It Matters
This filing provides shareholders with essential information regarding the BlackRock Health Sciences Term Trust, enabling them to make informed decisions about their investments and participate in corporate governance.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEFA14A) for a publicly traded company, not indicating any immediate operational or financial distress.
Key Numbers
- 811-23466 — SEC File Number (Identifies the specific registration for the Trust with the SEC.)
Key Players & Entities
- BlackRock Health Sciences Term Trust (company) — Registrant
- 1934 Act (legal_document) — Securities Exchange Act
- 811-23466 (legal_document) — SEC File Number
- 20240528 (date) — Filing Date
FAQ
What type of filing is this DEFA14A for BlackRock Health Sciences Term Trust?
This is a Definitive Proxy Statement filed pursuant to Section 14(a) of the Securities Exchange Act of 1934.
When was this filing made?
The filing was made on May 28, 2024.
What is the SEC file number for BlackRock Health Sciences Term Trust?
The SEC file number is 811-23466.
What is the former name of the company?
The former name was BlackRock Health Sciences Trust II, with a date of name change on August 20, 2019.
Where is the company's business address listed?
The business address is 100 Bellevue Parkway, Wilmington, DE 19809.
Filing Stats: 207 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2024-05-24 19:13:57
Filing Documents
- d796487ddefa14a.htm (DEFA14A) — 7KB
- g827124g01t01.jpg (GRAPHIC) — 174KB
- 0001193125-24-147260.txt ( ) — 248KB
From the Filing
HEALTH SCIENCES TERM TRUST BLACKROCK HEALTH SCIENCES TERM TRUST UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Definitive Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 BLACKROCK HEALTH SCIENCES TERM TRUST (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. Defend Your Fund Defend Your Fund (by BlackRock)1 followerPromoted ...The boards of BlackRocks CEFs work to protect and engage with all shareholders, and prioritize their need for steady income over time. Vote FOR BlackRocks CEF board nominees and AGAINST Sabas proposal using ONLY THE WHITE CARD. #DefendYourFundBlackRockBlackRock Closed-End Fund Investors:Our CEF boards have a duty to protect all investors.Vote FOR BlackRock board nominees todayBlackRock: CEFs Designed for Steady Income, Unique Value PropositionBlackrock.comLearn more